Is juvenile rheumatoid arthritis/juvenile idiopathic arthritis different from rheumatoid arthritis?

被引:24
|
作者
Prahalad, Sampath [1 ]
Glass, David N. [2 ]
机构
[1] Univ Utah, Sch Med, Dept Pediat, Div Rheumatol, Salt Lake City, UT USA
[2] Univ Cincinnati, Childrens Hosp, Dept Pediat, William S Rowe Div Rheumatol,Med Ctr,Coll Med, Cincinnati, OH USA
关键词
arthritis; classification/diagnosis; juvenile rheumatoid arthritis; rheumatoid;
D O I
10.1186/ar594
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The chronic arthropathies of childhood share clinical and pathological features with rheumatoid arthritis (RA) in adults. Both are autoimmune diseases characterized by a destructive arthropathy. Both are likely to be complex genetic traits, with autoantibodies and with a type-1-T-helper-cell cytokine profile in disease tissues. In common with other autoimmune diseases, both have associations and linkage with human keukocyte antigen (HLA) genetic markers. However, there are also important points of distinction outlined in this chapter, which include substantial differences in clinical phenotype. Juvenile rheumatoid arthritis (JRA) is characterized by several subtypes, whereas RA is more homogeneous. There are differences in outcome: adults with RA tend to have a poorer outcome; in JRA, the outcome is more variable and can be predicted by phenotypes at presentation. In addition, patients with RA have a stronger family history of RA although both RA and JRA share an increased frequency of family history of other autoimmune diseases. The genetic markers present to variable degrees in the subtypes of JRA differ quite considerably from those of RA. This is particularly so with respect to HLA.
引用
收藏
页码:S303 / S310
页数:8
相关论文
共 50 条
  • [1] Is juvenile rheumatoid arthritis/juvenile idiopathic arthritis different from rheumatoid arthritis?
    Sampath Prahalad
    David N Glass
    Arthritis Research & Therapy, 4
  • [2] Adalimumab in juvenile rheumatoid arthritis/juvenile idiopathic arthritis
    Marzan, Katherine Anne B.
    Reiff, Andreas Otto
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2008, 4 (05) : 549 - 558
  • [3] Novel therapies for the treatment of juvenile rheumatoid arthritis (juvenile idiopathic arthritis)
    Agle, LMA
    Rosenkranz, M
    Lehman, TJA
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (01) : 19 - 28
  • [4] FROM JUVENILE RHEUMATOID ARTHRITIS TO RHEUMATOID-ARTHRITIS
    MOZZICONACCI, P
    GAZETTE MEDICALE, 1985, 92 (10): : 25 - 25
  • [5] Adults with Juvenile Idiopathic Arthritis Are Not Adults with Rheumatoid Arthritis
    June, Rayford R.
    Feger, Danielle
    Longson, Nicholas
    Ostrov, Barbara E.
    Olsen, Nancy J.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [6] HDAC Inhibition in Rheumatoid Arthritis and Juvenile Idiopathic Arthritis
    Vojinovic, Jelena
    Damjanov, Nemanja
    MOLECULAR MEDICINE, 2011, 17 (5-6) : 397 - 403
  • [7] RENAL INVOLMENT IN RHEUMATOID ARTHRITIS AND JUVENILE IDIOPATHIC ARTHRITIS
    Porkodi, Ramanathan
    Rajendran, Panchapakesa
    RHEUMATOLOGY, 2011, 50 : 97 - 97
  • [8] HDAC Inhibition in Rheumatoid Arthritis and Juvenile Idiopathic Arthritis
    Jelena Vojinovic
    Nemanja Damjanov
    Molecular Medicine, 2011, 17 : 397 - 403
  • [9] Mizoribine in the treatment of rheumatoid arthritis and juvenile idiopathic arthritis
    Takei, S
    PEDIATRICS INTERNATIONAL, 2002, 44 (02) : 205 - 209
  • [10] Tocilizumab for rheumatoid and juvenile idiopathic arthritis
    Bongartz, Tim
    LANCET, 2008, 371 (9617): : 961 - 963